2026년 2월 17일 · Unknown · financial · 출처 Yahoo Finance
Feb 17 (Reuters) - Danaher will acquire pulse oximeter maker Masimo for $9.9 billion including debt, as the contract research firm looks to bulk up its diagnostics portfolio.
The companies said on Tuesday that Danaher will buy Masimo, which has been in a long legal battle with iPhone maker Apple over patents, for $180 per share. The offer represents a premium of 38.3% to Masimo's last close.
Contract research firms have been grappling with uncertainty around drug pricing regulations in the U.S., potential tariff policies and softer academic and government research funding.
Masimo has a market capitalization of about $7 billion, while Danaher is valued at over $150 billion, according to Reuters calculations.
(Reporting by Gnaneshwar Rajan and Christy Santhosh in Bengaluru; Editing by Mrigank Dhaniwala and Shinjini Ganguli)
View Comments